Table 2.
TFRC expression and clinicopathological characteristics of patients with CRC
| Characteristics | TFRC low experssion | TFRC high experssion | P | ||
|---|---|---|---|---|---|
| N | % | N | % | ||
| Gender | |||||
| Male | 11 | 22.0 | 11 | 22.0 | > 0.9999 |
| Female | 14 | 28.0 | 14 | 28.0 | |
| Age(years) | |||||
| < 56 | 13 | 26.0 | 12 | 24.0 | 0.7773 |
| > 56 | 12 | 24.0 | 13 | 26.0 | |
| Tumor size | |||||
| T1 or T2 | 9 | 45.0 | 3 | 6.0 | 0.0469* |
| T3 or T4 | 16 | 32.0 | 22 | 44.0 | |
| Lymph node | |||||
| N0 | 21 | 42.0 | 13 | 26.0 | 0.0502 |
| N1 | 3 | 6.0 | 10 | 20.0 | |
| N2 | 1 | 2.0 | 2 | 4.0 | |
| Grade | |||||
| 1 | 3 | 6.0 | 3 | 6.0 | 0.3080 |
| 2 | 17 | 34.0 | 17 | 34.0 | |
| 2–3 | 4 | 8.0 | 1 | 2.0 | |
| 3 | 1 | 2.0 | 4 | 8.0 | |
| Stage | |||||
| I | 9 | 18.0 | 1 | 2.0 | 0.0055* |
| II | 12 | 24.0 | 12 | 24.0 | |
| III-IV | 4 | 8.0 | 12 | 24.0 | |
* indicates P < 0.05